| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5927254 | American Heart Journal | 2013 | 7 Pages |
Abstract
African American patients undergoing percutaneous coronary intervention not only have a higher prevalence of HTPR to clopidogrel but also have higher CYP2C19*2 allele carrier status compared with whites. Careful selection of antiplatelet agents should be considered in an AA population at higher risk for ischemic complications.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Lakshmana K. MD, Rebecca MPH, Joshua P. MBBS, Joseph M. PhD, Fang PhD, Hironori MD, Sa'ar MD, Israel M. MD, William O. MD, Lowell F. MD, Augusto D. MD, Ron MD,